Hepatitis B virus-associated nephropathy

American Journal of Nephrology

Volumn 24, Issue 2, 2004, Pages 198-211

  Bhimma, Rajendra ^a   Coovadia, Hoosen Mohamed ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Hepatitis B virus; Interferon 2b; Membranous nephropathy; Nephrotic syndrome; Proteinuria

Indexed keywords

CORTICOSTEROID; CYTOKINE; HEMOGLOBIN E; HEPATITIS B VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; RECOMBINANT ALPHA2B INTERFERON; VIRUS ANTIGEN; VIRUS DNA;

AGE DISTRIBUTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ASSOCIATION; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFECT; EPIDEMIOLOGICAL DATA; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HISTOLOGY; HOST; HUMAN; IMMUNOLOGY; INCIDENCE; INJURY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS; MORBIDITY; MORTALITY; NEPHROTIC SYNDROME; PATHOGENESIS; PATHOLOGY; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEINURIA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REMISSION; REVIEW; SEX DIFFERENCE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION;

GLOMERULONEPHRITIS; HEPATITIS B; HUMANS; KIDNEY DISEASES; PROGNOSIS;

EID: 1842474839     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077065     Document Type: Review

References (115)

1. Bhimma R, Coovadia HM, Adhikari M: Hepatitis B virus-associated nephropathy in black South African children. Pediatr Nephrol 1998;12:479-484.
2. Combes B, Stastny P, Shorey J, Eigenbrodt EH, Barrera A, Hull AR, Carter NW: Glomerulonephritis with deposition of Australia antigenantibody complexes in glomerular basement membrane. Lancet 1971;ii:234-237.
3. Gocke DJ, Hsu K, Morgan C, Bombardien S, Locksmith M, Christian CL: Association between polyarteritis and Australia antigen. Lancet 1970;ii:1149-1156.
4. Levy Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC: Association between hepatitis B virus and essential mixed cyroglobulinemia. N Engl J Med 1977;296:1501-1508.
5. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M: Free 'small' and IgG-associated 'large' hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 1979;300:814-819.
6. Johnson RJ, Couser WG: Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990;37:663-676.
7. Norder H, Courouce AM, Magnius LO: Complete genomes, phylogenetic relatedness and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489-603.
8. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpens P: Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 1994;77:943-950.
9. Nassal H, Schaller H: Hepatitis B virus nucleocapsid assembly; in Doerfer W, Bohm P (eds): Virus Strategies. Weinheim, VCH, 1993, pp 41-75.
10. Onodera S, Ohon H, Yamaki M, Ishida N: Electron microscopy of human hepatitis B virus cores by negative staining - carbon film technique. J Med Virol 1992;10:147-155.
11. Gerlich WH, Robinson WS: Hepatitis B virus contains protein attached to 5′ terminus of its complete DNA strand. Cell 1980;21:801-809.
12. Marshall E: A shadow falls on hepatitis B vaccination effort. Science 1998;281:630-631.
13. Levy M, Chen N: Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int 1991;40(suppl 35):24-33.
14. Perrillo RP: Hepatitis B: Transmission and natural history. Gut 1993;(suppl):48-49.
15. Maynard JE, Kane MA, Alter MJ, Hadler SC: Control of hepatitis B by immunization; in Zuckerman AJ, Alan R (eds): Viral Hepatitis and Liver Disease. New York, Liss, 1988, pp 967-973.
16. Yang PM, Sung JL, Chen DS: HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepatogastroenterology 1989;36:363-366.
17. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SG, Dienstag JL, Awdeh Z, Yunis EJ: Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1984;321:708-712.
18. Kew MC: Chronic hepatitis B virus infection and hepatocellular carcinoma in Africa. S Afr J Sci 1992;88:524-528.
19. Nishioka K: Predominant mode of transmission of hepatitis B virus: Perinatal transmission in Asia; in Vyas GN, Dienstag JL, Hoofnagle JH: Viral Hepatitis and Liver Disease. Orlando, Grune & Stratton, 1984, pp 423-435.
20. Alter M, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, Mares A, Miller JK, Moyer LA: The changing epidemiology of hepatitis B in the United States. JAMA 1990;263:1218-1222.
21. Kew MC: Progress towards the comprehensive control of hepatitis B in Africa: A view from South Africa. Gut 1996;38(suppl 2):31-36.
22. Abdool Karim SS, Thejpal R, Coovadia HM: Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa. Int J Epidemiol 1991;20:495-503.
23. Botha JF, Ritchie MJJ, Dusheiko GM, Mouton HWK, Kew MC: Hepatitis B virus carrier state in black children in Ovamboland: Role of perinatal and horizontal infection. Lancet 1984;ii: 1210-1212.
24. Abdool Karim SS, Coovadia HM, Windsor IM, Thejpal R, van den Ende J, Fouche A: The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalised black children of Natal/KwaZulu, South Africa. Int J Epidemiol 1988;17:168-173.
25. Prozesky OW, Szmuness W, Stevens CE, Kew MC, Harley EJ, Hoyland JA, Scholtz JE, Mitchell AD, Shabangu A, Kunene E: Baseline epidemiological studies for a hepatitis B vaccine trial in KaNgwane. S Afr Med J 1983;64:891-893.
26. Whittle HC, Bradley HK, McLauchan K, Adjukiewicz AB, Howard CR, Zuckerman AJ, McGregor IA: Hepatitis B virus infection in two Gambian villages. Lancet 1983;i:1203-1206.
27. Barin F, Perrin J, Chotard J, Denis F, N'Doye R, Diop Mat I, Chiron JP, Coursaget P, Goudeau A, Maupas P: Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol 1981;27:148-162.
28. Murray-Lyon IM: Strategies for preventing hepatitis B. Quart J Med 1989;264:227-228.
29. Ching-Yuang L: Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int 1991;40(suppl 35):46-53.
30. Coovadia HM, Adhikari M, Moodley M: Hepatitis B 's' and 'e' antigen carriage in childhood nephrotic syndrome predicts membranous glomerulonephritis. Ann Trop Paediatr 1993;13:79-82.
31. Gilbert RD, Wiggelinkhuizen J: The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994;8:11-14.
32. Seggie J, Nathoo K, Davies PG: Association of hepatitis B (HB) antigenaemia and membranous glomerulonephritis in Zimbabwean children. Nephron 1984;38:115-119.
33. Adhikari M, Coovadia HM, Chrystal V: Extramembranous nephropathy in black South African children. Ann Trop Paediatr 1983;3:17-24.
34. Coovadia HM, Adhikari M, Morel-Maroger L: Clinico-pathological features of the nephrotic syndrome in South Africa. Q J Med 1979;48:77-91.
35. Wong V, Ip H, Reesink H, Lelie PN, Reerink-Brongers EE, Yeung CY, Ma HK: Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1984;i:921-926.
36. Takeoshi Y, Tanaka M, Shida N, Satake Y, Saheki Y, Matsumoto S: Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 1978;ii:1065-1068.
37. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J: The clinico-pathological features of hepatitis B virus associated glomerulonephritis. Q J Med 1987;63:323-333.
38. Hsu HC, Lin GH, Chang MH, Chen CH: Association of hepatitis B surface antigenaemia and membranous nephropathy in children in Taiwan. Clin Nephrol 1983;20:121-129.
39. Slusarczyk J, Michalark T, Nazarewick De Mezer T, Krawczynski K, Nowoslawski A: Membranous glomerulonephritis associated hepatitis B core antigen immune complexes. Am J Pathol 1980;98:29-39.
40. Knecht GI, Chrisari FV: Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. Gastroenterology 1978;75:1152-1154.
41. Takekoshi Y, Tochimaru H, Nagata Y, Itami N: Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int 1991;40(suppl 35):34-39.
42. Lai KN, Lai FM: Clinical features and natural history of hepatitis B virus-related glomerulopathy in adults. Kidney Int 1991;25(suppl):40-45.
43. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM: Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-1463.
44. Guillevin L, Lhote H, Cohen P, et al: Polyarteritis nodosa related hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1998;74:238.
45. Lisker-Melman M, Webb D, Di Bisceglie, A, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park J, Hoofnagle JH: Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant α-interferon. Ann Intern Med 1989;111:479-483.
46. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM: Longterm outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon-α. Gastroenterology 1995;109:540-546.
47. Abbas NA, Pitt MA, Green AT, Solomon LR: Successful treatment with hepatitis B virusassociated membranoproliferative glomerulonephritis with α-interferon. Nephrol Dial Transplant 1999;14:1272-1275.
48. Nagy J, Bajtai G, Brasch H, Sule T, Ambrus M, Deak G, Hamori A: The role of hepatitis N surface antigen in the pathogenesis of glomerulonephritis. Clin Nephrol 1979;12:109-116.
49. Lai KN, Lai FM, Lo S, Lam CW: IgA nephropathy associated with hepatitis B virus antigenemia. Nephron 1987;47:341-343.
50. Lai KN, Lai FM, Tam JS: IgA nephropathy associated with chronic hepatitis B virus infection in adults. J Pathol 1989;157:321-327.
51. Lai KN, Lai FM, Tam JS: Comparison of polyclonal and monoclonal antibodies in determination of glomerular deposits of hepatitis B virus antigens in hepatitis B virus-associated glomerulonephritis. Am J Clin Pathol 1989;92:159-165.
52. Lai KN, Lai FM, Tam JS, et al: High prevalence of hepatitis B surface antigenaemia in nephrotic syndrome in Hong Kong. Ann Trop Paediatr 1989;9:45-48.
53. Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslowski A: Glomerulonephritis associated with hepatitis B surface antigen immune complexes in children. Lancet 1974;ii:476-482.
54. Looi LM, Prathap K: Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 1982;6:141-147.
55. Lai KN, Lai FM, Leung A, Lo S: Is that a pathogenetic role of hepatitis B virus in lupus nephritis? Arch Pathol Lab Med 1987;111:185-188.
56. Gerber MA, Brodin A, Steinberg D, Vernace Y, Yang CP, Paronetto F: Periarteritis nodosa, Australia antigen and lymphatic leukaemia. N Engl J Med 1972;286:14-17.
57. Duffy J, Lidsky MD, Sharp JT, Davis JS, Person DA, Hollinger FB, Min KW: Polyarthritis, polyarteritis and hepatitis B. Medicine 1976;55:19-37.
58. Michalak T: Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases. Am J Pathol 1978;90:619-632.
59. Vehaskari VM, Robson AM: Proteinuria; in Eldelmann CM Jr, Bernstein J, Meadow SR, Spitzer A, Travis LB (eds): Pediatric Kidney Diseases, ed 2. Boston, Little Brown, 1992, pp 531-551.
60. Lai KN, Ho RTH, Tam JS, Lai FMM: Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis. Kidney Int 1996;50:1965-1977.
61. Couser WG, Salant DJ: In situ immune complex formation and glomerular injury. Kidney Int 1980;17:1-13.
62. Couser WG, Abrass CK: Pathogenesis of membranous nephropathy. Ann Res Med 1988;39:517-530.
63. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS: Association between the MHC class II allele and clearance of hepatitis virus in the Gambia. N Engl J Med 1995;332:1543-1546.
64. Germuth FG, Rodriguez E, Lorelle CA: Passive immune complex glomerulonephritis in mice: Models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits. Lab Invest 1979;41:366-372.
65. Lin CY: Hepatitis B virus associated membranous nephropathy: Clinical features, immunologic profiles and outcomes. Nephron 1990;55:37-44.
66. Ito H, Hattori S, Matsuda I, Amamiya S, Hajikano H, Yoshizawa H, Miyakawa Y, Mayumi M: Deposition of hepatitis B e antigen in membranous glomerulonephritis: Identification by F(ab′) fragments of monoclonal antibody. Kidney Int 1984;26:338-341.
67. 2 fragments of monoclonal antibody. Kidney Int 1984;26:338-341.
68. Ito H, Hattori S, Matsuda I, M, Amamiya S, Hajikano H, Yoshizawa H, Miyakawa Y, Mayumi M: Hepatitis B e antigen mediated membranous glomerulonephritis. Lab Invest 1981;44:214-220.
69. Lin CY, Lin CC, Chang GJJ, King CC: Defect of cell-mediated immune response against hepatitis B virus: An indication of pathogenesis of hepatitis B virus-associated membranous nephropathy. Nephron 1997;76:176-185.
70. Xin YH, Li JF, Yue EZ, Fanh YS, Xu RZ, Mu YG: In situ hybridisation of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998;12:117-120.
71. Zhou SD, Zhang YE, Guo MY, Fang LJ, Zhang XR, Zhang M, Wu Z, Lin SY, Liao LT: The study of the significance of the appearance of HbcAg in glomerulonephritis. Chin J Nephrol 1995;11:104-106.
72. Eddleston ALWF, Mondelli M: Immunopathological mechanisms of liver cell injury in chronic hepatitis B virus infection. J Hepatol 1986;3(suppl 2):17-23.
73. Dudley FJ, Fox RA, Sherlock S: Cellular immunity and hepatitis- associated Australia antigen liver disease. Lancet 1972;i:723-726.
74. London WT, Drew JS, Lustbader ED, Werner BG, Blumberg BS: Host responses to hepatitis B infection in patients in a chronic haemodialysis unit. Kidney Int 1977;12:51-58.
75. Ramjee G: Studies of the mechanisms of proteinuria in kidney diseases of childhood; thesis, University of Natal, Durban, South Africa 1994.
76. Bhimma R, Hammond MG, Coovadia HM, Adhikari M, Connolly CA: HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int 2002;61:1510-1515.
77. Bhimma R, Hammond MG, Coovadia HM, Kramvis A, Adhikari M, Kew MC: HLA associations with HBV carriage and proteinuria. Pediatr Nephrol 2002;17:724-729.
78. Vaughan RW, Zurowska A, Moszkowska G, et al: HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy. Tissue Antigens 1998;52:130-134.
79. Levy M, Kleinknecht C, Droz D, Dreuke T: Glomerular diseases and hepatitis B virus. Adv Nephrol 1982;11:341-370.
80. Lai KN, Tam JS, Lin HJ, Lai FM: The therapeutic dilemma of usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B surface antigenemia. Nephron 1990;54:12-17.
81. Knieser MR, Jenis EH, Lowenthal DT, Bancroft WH, Burns W, Shalhoub R: Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol 1974;97:193-200.
82. Guerra IL, Abraham AA, Kimmel PL, Sabnis SG, Antonovych T: Nephrotic syndrome associated with chronic persistent hepatitis B in a HIV antibody positive patient. Am J Kidney Dis 1987;10:385-388.
83. Cogan MG, Graber ML, Connor DG: Chronic active hepatitis and membranous nephropathy. Am J Gastroenterol 1977;68:386-391.
84. Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V: Membranous glomerulonephritis and hepatitis B surface antigenemia. J Pediatr 1979;95:946-952.
85. Kohler PF, Chronin RE, Hammond WS, Olin D, Carr RI: Chronic membranous glomerulonephritis caused by hepatitis antigen-antibody immune complexes. Ann Intern Med 1974;81:448-451.
86. Hsu HC, Wu CY, Lin CY, Lin GJ, Chen CH, Huang FY: Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. Kidney Int 1989;36:1103-1107.
87. Southwest Pediatric Nephrology Study Group: Hepatitis B surface antigenaemia in North American children with membranous glomerulonephropathy. J Pediatr 1985;106:571-557.
88. Furuse A, Hattori S, Terashima T, Karashima S, Matsuda I: Circulating immune complex in glomerulopathy associated with hepatitis B virus infection. Nephron 1982;31:212-218.
89. Cadrobbi P, Bortolotti F, Zacchello G, Rinaldi R, Armigliato M, Realdi G: Hepatitis B virus replication in acute glomerulonephritis with chronic active hepatitis. Arch Dis Child 1985;60:583-585.
90. Hoofnagle JH, Davis MD, Pappas C, Hanson RG, Peters M, Avigon MI, Waggoner JG, Jones EA, Seeff LB: A short course of prednisolone in chronic type B hepatitis. Ann Intern Med 1986;104:12-17.
91. Lai FM, Tam JS, Li P, Lai KN: Replication of hepatitis B virus with corticosteriod therapy in hepatitis B virus-related membranous nephropathy. Virchows Arch Pathol Anat 1989;414:279-284.
92. Haria M, Banfield P: Interferon-α2a: A review of its pharmacological properties and therapeutic use in management of viral hepatitis. Drugs 1995;50:873-896.
93. Phillips TM: Interferon-α induces renal dysfunction and injury. Curr Opin Nephrol Hypertens 1996;5:380-383.
94. Belardelli F, Gressor I: The neglected role of type 1 interferon in the T-cell response: Implications for its clinical use. Immunol Today 1996;17:369-372.
95. Wakeel JA, Mitwalli A, Tarif N, Al-Mohaya S, Malik G, Khalil M: Role of interferon-α in the treatment of primary glomerulonephritis. Am J Kidney Dis 1999;33:1142-1146.
96. Wong DK, Cheung AM, Órourke K, Naylor CD, Detsky AS, Heathcote J: Effect of α-interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312-323.
97. Lin CY: Treatment of hepatitis B virus-associated membranous nephropathy with recombinant α-interferon. Kidney Int 1991;47:225-230.
98. Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC: Treatment of hepatitis B virus-associated nephropathy in black children. Pediatr Nephrol 2002;17:393-399.
99. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, Dienstag JL, Obrien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Alrecht J, Gibas A and the Hepatitis Interventional Therapy Group: A randomised, controlled trial of interferon-α2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990;5:295-301.
100. Whittle HC, Pilkington J, Mendy M, Maine N, Fortuin M, Bunn J, Allison L, Howard C: Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995;345:1089-1092.
101. Kew MC: Protective efficacy of hepatitis B vaccination. Lancet 1995;345:1065-1066.
102. Hsu HM, Chen DS, Chaung CH, Lu JC, Jwo DM, Lee CC, Lu HC, Cheng SH, Wang YF, Wang CY: Efficacy of a mass hepatitis B vaccination program in Taiwan. JAMA 1998;260:2231-2235.
103. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS: Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: Five years after a mass hepatitis B vaccination program. J Med Virol 1991;34:96-99.
104. Wu WS, Shao ZP: A review of hepatitis B immunisation. Chin J Vaccine Immun 1996;2:61-66.
105. Line XM, Xu ZY, Ouyang PY, et al: Eight year survey for hepatitis B vaccine efficacy to newborns after universal immunisation. Chin J Exp Virol 1995;9:55-58.
106. Li RC, Yang JY, Wang SS, et al: The effect of hepatitis B vaccination on epidemiology of hepatitis virus. Chin J Vaccine Immun 1996;2:56-60.
107. Safary A, Beck J: Vaccination against hepatitis B: Current challenges for Asian countries and future directions. J Gastroenterol Hepatol 2000;15:396-401.
108. Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 1981;ii:1129-1133.
109. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;36:1855-1859.
110. Zhao S, Xu Z, Lu Y: A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol 2000;29:744-752.
111. Zuckerman AJ: Prevention of primary liver cancer by immunisation. N Engl Med 1997;26:1906-1907.
112. Lee CL, Ko YC: Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997;99:351-353.
113. Chen DS, Sung JL: Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepatogastroenterol 1978;25:423-430.
114. Kane M: Status of hepatitis V immunisation programmes in 1998. Vaccine 1998;16(suppl):104-108.
115. The People of South Africa, Population census 1996. Statistics South Africa 1998, pp 4-22.